As of 2024-12-13, the Relative Valuation of CVS Health Corp (CVS) is 104.85 USD. This relative valuation is based on P/E multiples. With the latest stock price at 49.58 USD, the upside of CVS Health Corp based on Relative Valuation is 111.5%.
The range of the Relative Valuation is 80.60 - 135.94 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.2x - 26.5x | 23.3x |
| Forward P/E multiples | 15.3x - 19.8x | 17.0x |
| Fair Price | 80.60 - 135.94 | 104.85 |
| Upside | 62.6% - 174.2% | 111.5% |
| Date | P/E |
| 2024-12-12 | 12.44 |
| 2024-12-11 | 12.99 |
| 2024-12-10 | 13.84 |
| 2024-12-09 | 14.07 |
| 2024-12-06 | 13.87 |
| 2024-12-05 | 14.26 |
| 2024-12-04 | 14.56 |
| 2024-12-03 | 14.85 |
| 2024-12-02 | 14.82 |
| 2024-11-29 | 15.02 |
| 2024-11-27 | 15.04 |
| 2024-11-26 | 14.80 |
| 2024-11-25 | 15.07 |
| 2024-11-22 | 14.55 |
| 2024-11-21 | 14.33 |
| 2024-11-20 | 14.26 |
| 2024-11-19 | 13.99 |
| 2024-11-18 | 14.06 |
| 2024-11-15 | 13.34 |
| 2024-11-14 | 13.82 |
| 2024-11-13 | 13.62 |
| 2024-11-12 | 13.56 |
| 2024-11-11 | 14.00 |
| 2024-11-08 | 13.93 |
| 2024-11-07 | 14.32 |
| 2024-11-06 | 15.46 |
| 2024-11-05 | 13.88 |
| 2024-11-04 | 13.71 |
| 2024-11-01 | 14.00 |
| 2024-10-31 | 14.16 |
| 2024-10-30 | 14.15 |
| 2024-10-29 | 14.11 |
| 2024-10-28 | 14.39 |
| 2024-10-25 | 14.17 |
| 2024-10-24 | 14.08 |
| 2024-10-23 | 14.24 |
| 2024-10-22 | 14.26 |
| 2024-10-21 | 14.59 |
| 2024-10-18 | 15.14 |
| 2024-10-17 | 15.97 |
| 2024-10-16 | 16.31 |
| 2024-10-15 | 16.31 |
| 2024-10-14 | 16.92 |
| 2024-10-11 | 16.72 |
| 2024-10-10 | 16.77 |
| 2024-10-09 | 16.55 |
| 2024-10-08 | 16.53 |
| 2024-10-07 | 16.37 |
| 2024-10-04 | 16.20 |
| 2024-10-03 | 15.79 |